Top Markets
#1 MowCat MowCat +49.01%
#2 Derive Derive +24.21%
#3 Audiera Audiera +23.59%
#4 Geodnet Geodnet +16.54%
#5 aPriori aPriori +15.50%
#6 Cross Cross +14.04%
#7 Biconomy Biconomy +13.72%
#8 Humanity Humanity +11.92%
#9 Quack AI Quack AI +11.55%
#10 Velvet Velvet +11.26%
Coin of the day
MowCat MowCat
설정
언어
한국어
통화
USD
테마
Tetra Bio-Pharma Inc. Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Inc.

TBP
주식 순위 #35576
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
주가
$0.01851783
마지막 동기화: 2023-05-23
시가총액
$3.71M
변동 (1일)
-0.04%
변동 (1년)
0.00%
국가
CA
거래 Tetra Bio-Pharma Inc. (TBP)

카테고리

Healthcare
Tetra Bio-Pharma Inc. (TBP)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
Tetra Bio-Pharma Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
Tetra Bio-Pharma Inc.의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE